Harrow Health Inc HROWL:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 4:00 PM EST
23.90quote price arrow down-0.10 (-0.42%)
Volume
23,463
52 week range
22.24 - 26.50
Loading...
  • Open24.10
  • Day High24.10
  • Day Low23.85
  • Prev Close24.00
  • 52 Week High26.50
  • 52 Week High Date02/03/22
  • 52 Week Low22.24
  • 52 Week Low Date06/14/22

Key Stats

  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume0.01M
  • Dividend2.16
  • Dividend Yield9.02%
  • Beta-
  • YTD % Change0.55

KEY STATS

  • Open24.10
  • Day High24.10
  • Day Low23.85
  • Prev Close24.00
  • 52 Week High26.50
  • 52 Week High Date02/03/22
  • 52 Week Low22.24
  • 52 Week Low Date06/14/22
  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume0.01M
  • Dividend2.16
  • Dividend Yield9.02%
  • Beta-
  • YTD % Change0.55

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date01/12/2023
  • Div Amount0.5391
  • Split Date-
  • Split Factor-

Latest On Harrow Health Inc

 

Profile

MORE
Harrow Health, Inc. is an eyecare pharmaceutical company. The Company serves ophthalmologists and optometrists by providing branded ophthalmic pharmaceuticals and compounded prescription medicines. The Company's business specializes in the development, production and sale of medications that serve unmet needs in the marketplace through its subsidiaries and deconsolidated companies. Its five branded ophthalmic products include ILEVRO, NEVANAC, VIGAMOX, MAXIDEX, and TRIESENCE....
Mark Baum J.D.
Chairman of the Board, Chief Executive Officer
Andrew Boll
Chief Financial Officer, Corporate Secretary
Address
102 WOODMONT BLVD, SUITE 610
Nashville, TN
37215
United States